Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics

Leukemia Research

Volumn 33, Issue 3, 2009, Pages 418-425

  Reid, Alistair G ^a   De Melo, Valeria A ^a   Elderfield, Kay ^a   Clark, Ian ^a   Marin, David ^a   Apperley, Jane ^a   Naresh, Kikkeri N ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Accelerated phase; Blast crisis; Bone marrow trephine biopsy; Chronic myeloid leukemia

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOBLAST; BLAST CELL CRISIS; BONE MARROW BIOPSY; CHROMOSOME 17P; CHROMOSOME 3Q; CHROMOSOME LOSS; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; HUMAN; IMMUNOPHENOTYPING; LYMPHOID BLASTIC CRISIS; MAJOR CLINICAL STUDY; MYELOBLAST; MYELOID BLASTIC CRISIS; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; TRISOMY;

BIOPSY; BLAST CRISIS; BONE MARROW; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PHENOTYPE; RETROSPECTIVE STUDIES;

EID: 58549099651     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.07.019     Document Type: Article

References (25)

1. Vardiman J.W., Pierre R., Thiele J., Imbert M., Brunning R.D., and Flandrin G. Chronic myeloenous leukaemia. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France 20
2. Ch'ang H.J., Tien H.F., Wang C.H., Chuang S.M., Chen Y.C., Shen M.C., et al. Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia. Cancer Genet Cytogenet 71 November (1) (1993) 87-93
3. Dorfman D.M., Longtine J.A., Fox E.A., Weinberg D.S., and Pinkus G.S. T-cell blast crisis in chronic myelogenous leukaemia. Immunophenotypic and molecular biologic findings. Am J Clin Pathol 107 February (2) (1997) 168-176
4. Scolnik M.P., Palacios M.F., Acevedo S.H., Castuma M.V., Larripa I.B., Palumbo A., et al. Promyelocytic blast crisis of chronic myelogenous leukaemia with translocations (9;22) and (15;17). Leuk Lymphoma 31 September (1-2) (1998) 231-236
5. Elliot V., Marin D., Horncastle D., Elderfield K., Apperley J.F., Lampert I.A., et al. Percentage of CD34 cells in a minimum 500-cell count in bone marrow trephines of patients with chronic myeloid leukaemia provides the best correlation with aspirate blast count. Br J Haematol 130 August (3) (2005) 460-461
6. Przepiorka D., and Thomas E.D. Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia. Bone Marrow Transplant 3 March (2) (1988) 113-119
7. Khalidi H.S., Brynes R.K., Medeiros L.J., Chang K.L., Slovak M.L., Snyder D.S., et al. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and a comparison of morphologic, immunophenotypic, and molecular findings. Mod Pathol 11 December (12) (1998) 1211-1221
8. Nair C., Chopra H., Shinde S., Barbhaya S., Kumar A., Dhond S., et al. Immunophenotype and ultrastructural studies in blast crisis of chronic myeloid leukemia. Leuk Lymphoma 19 October (3-4) (1995) 309-313
9. Saikia T., Advani S., Dasgupta A., Ramakrishnan G., Nair C., Gladstone B., et al. Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping-experience in 60 patients. Leuk Res 12 6 (1988) 499-506
10. Urbano-Ispizua A., Cervantes F., Matutes E., Villamor N., Pujades A., Sierra J., et al. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival. Leukemia 7 September (9) (1993) 1349-1354
11. Islam A., Catovsky D., Goldman J.M., and Galton D.A. Bone marrow biopsy changes in acute myeloid leukaemia. I. Observations before chemotherapy. Histopathology 9 September (9) (1985) 939-957
12. Naresh K.N., Lampert I., Hasserjian R., Lykidis D., Elderfield K., Horncastle D., et al. Optimal processing of bone marrow trephine biopsy: the Hammersmith protocol. J Clin Pathol 59 September (9) (2006) 903-911
13. Attias D., and Weitzman S. The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Curr Opin Pediatr 20 February (1) (2008) 17-22
14. Gokbuget N., and Hoelzer D. Novel antibody-based therapy for acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 19 4 (2006) 701-713
15. Diez-Martin J.L., Dewald G.W., and Pierre R.V. Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia. Am J Hematol 27 March (3) (1988) 194-203
16. Murakami T., Ohyashiki K., Ohyashiki J.H., Kawakubo K., Tauchi T., Nakazawa S., et al. Cytogenetic and immunogenotypic alterations of blast crisis cells in chronic myelogenous leukemia independently linked to immunophenotypic expression. Cancer Genet Cytogenet 72 January (1) (1994) 48-54
17. Yin C.C., Cortes J., Barkoh B., Hayes K., Kantarjian H., and Jones D. T(3;21)(q26;q22) in Myeloid Leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy. Cancer 106 April 15 (8) (2006) 1730-1738
18. Ohyashiki J.H., Ohyashiki K., Shimamoto T., Kawakubo K., Fujimura T., Nakazawa S., et al. Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression. Blood 85 June 15 (12) (1995) 3713-3718
19. Heim S., Christensen B.E., Fioretos T., Sorensen A.G., and Pedersen N.T. Acute myelomonocytic leukemia with inv(16)(p13;q22) complicating Philadelphia chromosome positive chronic myeloid leukemia. Cancer Genet Cytogenet 59 March (1) (1992) 35-38
20. Merzianu M., Medeiros L.J., Cortes J., Yin C., Lin P., Jones D., et al. Inv(16)(p13;q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol 124 November (5) (2005) 807-814
21. Gozzetti A., Bocchia M., Calabrese S., Pirrotta M.T., Crupi R., Raspadori D., et al. Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment. Acta Haematol 117 4 (2007) 236-237
22. Nishii K., Usui E., Sakakura M., Miyata E., Ridge S.A., Ford A.M., et al. Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia. Cancer Genet Cytogenet 126 April 1 (1) (2001) 8-12
23. Suzuki K., Sugawara T., Kowata S., Utsugizawa T., Ito S., Murai K., et al. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet 150 April 15 (2) (2004) 159-163
24. Shimizu S., Nagasawa T., Katoh O., Komatsu N., Yokota J., and Morishita K. EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation. Biochem Biophys Res Commun 292 April 5 (3) (2002) 609-616
25. Panani A.D., Stamouli M., Harhalakis N., Nikiforakis M., and Roussos C. A complex karyotype in promyelocytic-like blastic transformation of Ph-positive chronic myeloid leukemia. Cancer Genet Cytogenet 158 April 1 (1) (2005) 92-94